Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

androgel

AbbVie hit with $140m fine over fraudulent marketing of Androgel

October 6, 2017 Medical Communications, Sales and Marketing AbbVie, androgel, biotech, drugs, pharma, pharmaceutical

AbbVie has been stung with a $140 million damages award to a man that suffered a heart attack after using …
News

At least 40% of Afghanistan’s medicine imported illegally, union claims

October 6, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing afghanistan, pharma, pharmaceuticals

New damning allegations have arisen concerning Afghanistan’s pharmaceutical industry, as the Medicine Importers Union claims that at least 40% of …
News
bayer_cross_2

Bayer forced to halt huge study into key drug

October 6, 2017 Medical Communications, Research and Development Bayer, Janssen, Xarelto, biotech, drugs, pharma, pharmaceutical

Bayer, and development partner Janssen, have been forced to stop a Phase 3 trial looking at expanding the indication of …
News
aspen

South Africa’s over-charging case against Aspen dissolves, remains against big names

October 6, 2017 Medical Communications, Sales and Marketing Genentech, Pfizer, Roche, aspen, biotech, drugs, pharma, pharmaceutical

South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …
News

Merck KGaA promotes from within new MEA head

October 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA has installed a new head of its healthcare business for the Middle East, Africa and Turkey (MEA) region, …
Appointment
culture

Gonorrhoea is just the tip of the antimicrobial resistance iceberg

October 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NovaBiotics, biotech, drugs, gonorrhoea, pharma, pharmaceutical

Dr Deborah O’Neil, Chief Executive and Scientific Officer at NovaBiotics, discusses the WHO-recognised threat of ‘super gonorrhoea’ and the antimicrobial …
Feature
meeker_david_2015_004low_0

KSQ Therapeutics emerges from shadows, with former Genzyme CEO at helm

October 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meeker, KSQ Therapeutics, biotech, drugs, pharma, pharmaceutical

KSQ Therapeutics has been known of for the last two years, when it was originally founded, but now it has …
Appointment
fpr4et-xlarge_trans_nvbqzqnjv4bqrqsyshnmi5jqhkavocpkgbkoqxwcrp1qzr8w2tfjptk

England set to adopt opt-out organ donation

October 5, 2017 Medical Communications biotech, drugs, organ donation, pharma, pharmaceutical

In a major change for the healthcare system in England, admittedly one that was easy to be lost among the …
News
cholera_infection_map

Global campaign to reduce cholera deaths by 90%

October 4, 2017 Medical Communications, Research and Development Cholera, WHO, biotech, drugs, pharma, pharmaceutical

A new campaign, launched by the WHO, has begun today to reduce deaths from cholera by 90% through to 2030. …
News
flu_vaccine

‘Universal flu vaccine’ to be trialed this winter

October 3, 2017 Manufacturing and Production, Medical Communications Flu virus, Vaccine, biotech, drugs, influenza, pharma, pharmaceutical

Researchers are enrolling 500 participants for the trial of a flu vaccine to protect the population against all strains of …
News
astrazeneca_logo_building

AstraZeneca Chairman wants three-year Brexit transition period

October 3, 2017 Manufacturing and Production, Medical Communications AstraZeneca, biotech, brexit, drugs, pharma, pharmaceutical

The Chairman of AstraZeneca, Leif Johansson, revealed in no uncertain terms that his company would like there to be a …
News

Overcoming real-world challenges to maximise the benefit of treatment for patients with multiple myeloma

October 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, multiple myeloma

Dr Antonio Palumbo, Distinguished Research Fellow Oncology, Takeda Pharmaceuticals addresses hwo far we’ve come in treating multiple myeloma, and how …
Feature
lilly_logo_2

Lilly reveals major senior leadership reshuffle

October 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, biotech, drugs, pharma, pharmaceutical

Eli Lilly revealed on 29 September that it would promote four staff members to senior staff positions, and two senior …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, EMA, FDA, HIV, J&J, JJ, Kevzara, Mylan, NICE, Sanofi, nash, top ten

It’s Friday, and it’s time for another round up of the most popular articles on pharmafile.com over the last seven …
News
gilead_senior_management

Gilead’s COO retires, shares take a dive

September 29, 2017 Medical Communications Gilead, Kevin Young, biotech, drugs, pharma, pharmaceutical

Gilead has announced that Kevin Young, its Chief Operating Officer, is set to retire from the company in early 2018. …
News
The Gateway to Local Adoption Series

Latest content

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026

Vetter begins construction of new injectable medicines facility

May 20, 2026